Methylphenidat Spirig HC retard 18 mg
Methylphenidat Spirig HC retard 18 mg is a medicine authorised by Swissmedic under authorisation number 69315. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 04 January 2024 and the authorisation is limited until 03 January 2029. ATC code N06BA04 places the medicine in the group Psychoanaleptics.
| Authorisation number | 69315 |
|---|---|
| Name | Methylphenidat Spirig HC retard 18 mg |
| Full name | Methylphenidat Spirig HC retard 18 mg, Retardtabletten |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A+ · Prescription with conditions |
| ATC code | N06BA04 |
| First authorisation | 04 January 2024 |
| Authorisation validity | 03 January 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Methylphenidat Spirig HC retard 18 mg, Retardtabletten | A+ | 04 January 2024 |
| 2 | Methylphenidat Spirig HC retard 27 mg, Retardtabletten | A+ | 04 January 2024 |
| 3 | Methylphenidat Spirig HC retard 36 mg, Retardtabletten | A+ | 04 January 2024 |
| 4 | Methylphenidat Spirig HC retard 54 mg, Retardtabletten | A+ | 04 January 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
| 2 | 60 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
| 3 | 30 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
| 4 | 60 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
| 5 | 30 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
| 6 | 60 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
| 7 | 30 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
| 8 | 60 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Methylphenidat Spirig HC retard 18 mg authorised in Switzerland?
Yes. Methylphenidat Spirig HC retard 18 mg is authorised by Swissmedic under authorisation number 69315, data as of 01 September 2026. The authorisation is limited until 03 January 2029.
Which dispensing category does Methylphenidat Spirig HC retard 18 mg have?
Methylphenidat Spirig HC retard 18 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.
Who is the authorisation holder of Methylphenidat Spirig HC retard 18 mg?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.